PMC:7195088 / 25376-25688 JSONTXT

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T125","span":{"begin":67,"end":75},"obj":"Disease"},{"id":"T126","span":{"begin":118,"end":126},"obj":"Disease"}],"attributes":[{"id":"A125","pred":"mondo_id","subj":"T125","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A126","pred":"mondo_id","subj":"T126","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"• In a recent RCT published on a preprint server and comparing 120 COVID-19 patients treated with favipiravir vs. 120 COVID-19 patients receiving umifenovir, higher rates of clinical recovery were observed in patients receiving favipiravir. The manuscript is publicly available but still to be peer reviewed [30]"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T126","span":{"begin":5,"end":6},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T127","span":{"begin":31,"end":32},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T128","span":{"begin":294,"end":298},"obj":"http://purl.obolibrary.org/obo/CLO_0008416"},{"id":"T129","span":{"begin":294,"end":298},"obj":"http://purl.obolibrary.org/obo/CLO_0050081"}],"text":"• In a recent RCT published on a preprint server and comparing 120 COVID-19 patients treated with favipiravir vs. 120 COVID-19 patients receiving umifenovir, higher rates of clinical recovery were observed in patients receiving favipiravir. The manuscript is publicly available but still to be peer reviewed [30]"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T344","span":{"begin":98,"end":109},"obj":"Chemical"},{"id":"T345","span":{"begin":146,"end":156},"obj":"Chemical"},{"id":"T346","span":{"begin":228,"end":239},"obj":"Chemical"}],"attributes":[{"id":"A344","pred":"chebi_id","subj":"T344","obj":"http://purl.obolibrary.org/obo/CHEBI_134722"},{"id":"A345","pred":"chebi_id","subj":"T345","obj":"http://purl.obolibrary.org/obo/CHEBI_134730"},{"id":"A346","pred":"chebi_id","subj":"T346","obj":"http://purl.obolibrary.org/obo/CHEBI_134722"}],"text":"• In a recent RCT published on a preprint server and comparing 120 COVID-19 patients treated with favipiravir vs. 120 COVID-19 patients receiving umifenovir, higher rates of clinical recovery were observed in patients receiving favipiravir. The manuscript is publicly available but still to be peer reviewed [30]"}